Literature DB >> 19193898

The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits.

Sean B Christie1, Michael R Akins, James E Schwob, Justin R Fallon.   

Abstract

The loss of Fragile X mental retardation protein (FMRP) causes Fragile X syndrome, the most common inherited mental retardation and single gene cause of autism. Although postsynaptic functions for FMRP are well established, potential roles at the presynaptic apparatus remain largely unexplored. Here, we characterize the expression of FMRP and its homologs, FXR1P and FXR2P, in the developing, mature and regenerating rodent nervous system, with a focus on presynaptic expression. As expected, FMRP is expressed in the somatodendritic domain in virtually all neurons. However, FMRP is also localized in discrete granules (Fragile X granules; FXGs) in a subset of brain regions including frontal cortex, hippocampal area CA3 and olfactory bulb glomeruli. Immunoelectron microscopy shows that FMRP is localized at presynaptic terminals and in axons within these FXG-rich regions. With the exception of the olfactory bulb, FXGs are prominent only in the developing brain. Experiments in regenerating olfactory circuits indicate that peak FXG expression occurs 2-4 weeks after neurogenesis, a period that correlates with synapse formation and refinement. Virtually all FXGs contain FXR2P, while region-selective subsets harbor FMRP and/or FXR1P. Genetic studies show that FXR2P is essential for FXG expression, while FMRP regulates FXG number and developmental profile. These findings suggest that Fragile X proteins play a distinct, presynaptic role during discrete developmental epochs in defined circuits of the mammalian CNS. We propose that the neurological defects in Fragile X syndrome, including the autistic features, could be due in part to the loss of FMRP function in presynaptic compartments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193898      PMCID: PMC2746438          DOI: 10.1523/JNEUROSCI.3937-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Development and characterization of antibodies that immunoprecipitate the FMR1 protein.

Authors:  Stephanie Ceman; Fuping Zhang; Tamika Johnson; Stephen T Warren
Journal:  Methods Mol Biol       Date:  2003

2.  Altered synaptic plasticity in a mouse model of fragile X mental retardation.

Authors:  Kimberly M Huber; Sean M Gallagher; Stephen T Warren; Mark F Bear
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

3.  Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function.

Authors:  Y Q Zhang; A M Bailey; H J Matthies; R B Renden; M A Smith; S D Speese; G M Rubin; K Broadie
Journal:  Cell       Date:  2001-11-30       Impact factor: 41.582

4.  Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination.

Authors:  S A Irwin; B Patel; M Idupulapati; J B Harris; R A Crisostomo; B P Larsen; F Kooy; P J Willems; P Cras; P B Kozlowski; R A Swain; I J Weiler; W T Greenough
Journal:  Am J Med Genet       Date:  2001-01-15

5.  Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse.

Authors:  C E Bakker; Y de Diego Otero; C Bontekoe; P Raghoe; T Luteijn; A T Hoogeveen; B A Oostra; R Willemsen
Journal:  Exp Cell Res       Date:  2000-07-10       Impact factor: 3.905

6.  Knockout mouse model for Fxr2: a model for mental retardation.

Authors:  Carola J M Bontekoe; Kellie L McIlwain; Ingeborg M Nieuwenhuizen; Lisa A Yuva-Paylor; Anna Nellis; Rob Willemsen; Zhe Fang; Laura Kirkpatrick; Cathy E Bakker; Robin McAninch; Ngan Ching Cheng; Michelle Merriweather; Andre T Hoogeveen; David Nelson; Richard Paylor; Ben A Oostra
Journal:  Hum Mol Genet       Date:  2002-03-01       Impact factor: 6.150

7.  RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice.

Authors:  Kevin Y Miyashiro; Andrea Beckel-Mitchener; T Patrick Purk; Kevin G Becker; Tanya Barret; Lei Liu; Salvatore Carbonetto; Ivan Jeanne Weiler; William T Greenough; James Eberwine
Journal:  Neuron       Date:  2003-02-06       Impact factor: 17.173

8.  Localized synaptic potentiation by BDNF requires local protein synthesis in the developing axon.

Authors:  Xiao hui Zhang; Mu-ming Poo
Journal:  Neuron       Date:  2002-11-14       Impact factor: 17.173

Review 9.  A decade of molecular studies of fragile X syndrome.

Authors:  William T O'Donnell; Stephen T Warren
Journal:  Annu Rev Neurosci       Date:  2002-03-20       Impact factor: 12.449

Review 10.  Fragile X syndrome, the Fragile X related proteins, and animal models.

Authors:  André T Hoogeveen; Rob Willemsen; Ben A Oostra
Journal:  Microsc Res Tech       Date:  2002-05-01       Impact factor: 2.769

View more
  111 in total

Review 1.  Fragile X syndrome: the GABAergic system and circuit dysfunction.

Authors:  Scott M Paluszkiewicz; Brandon S Martin; Molly M Huntsman
Journal:  Dev Neurosci       Date:  2011-09-21       Impact factor: 2.984

Review 2.  Cytoplasmic RNA-binding proteins and the control of complex brain function.

Authors:  Jennifer C Darnell; Joel D Richter
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

3.  Axonal ribosomes and mRNAs associate with fragile X granules in adult rodent and human brains.

Authors:  Michael R Akins; Hanna E Berk-Rauch; Kenneth Y Kwan; Molly E Mitchell; Katherine A Shepard; Lulu I T Korsak; Emily E Stackpole; Jennifer L Warner-Schmidt; Nenad Sestan; Heather A Cameron; Justin R Fallon
Journal:  Hum Mol Genet       Date:  2017-01-01       Impact factor: 6.150

4.  Molecular and genetic analysis of the Drosophila model of fragile X syndrome.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Results Probl Cell Differ       Date:  2012

5.  Fragile X mental retardation protein (FMRP) and the spinal sensory system.

Authors:  Theodore J Price; Ohannes K Melemedjian
Journal:  Results Probl Cell Differ       Date:  2012

6.  The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.

Authors:  Jose Luis Olmos-Serrano; Joshua G Corbin; Mark P Burns
Journal:  Dev Neurosci       Date:  2011-11-08       Impact factor: 2.984

7.  Cell type-dependent axonal localization of translational regulators and mRNA in mouse peripheral olfactory neurons.

Authors:  Lulu I T Korsak; Katherine A Shepard; Michael R Akins
Journal:  J Comp Neurol       Date:  2017-03-26       Impact factor: 3.215

8.  Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration.

Authors:  Laura N Smith; Jakub P Jedynak; Miles R Fontenot; Carly F Hale; Karen C Dietz; Makoto Taniguchi; Feba S Thomas; Benjamin C Zirlin; Shari G Birnbaum; Kimberly M Huber; Mark J Thomas; Christopher W Cowan
Journal:  Neuron       Date:  2014-05-07       Impact factor: 17.173

9.  Fragile X mental retardation protein regulates olfactory sensitivity but not odorant discrimination.

Authors:  Arielle Schilit Nitenson; Emily E Stackpole; Torrey L S Truszkowski; Maellie Midroit; Justin R Fallon; Kevin G Bath
Journal:  Chem Senses       Date:  2015-04-27       Impact factor: 3.160

Review 10.  The translation of translational control by FMRP: therapeutic targets for FXS.

Authors:  Jennifer C Darnell; Eric Klann
Journal:  Nat Neurosci       Date:  2013-04-14       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.